Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsLymphocytesGraft vs Host DiseaseTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationGraft SurvivalTransplantation ConditioningAnemia, AplasticKidney TransplantationLeukemiaLiver TransplantationTransplantation ChimeraLymphocyte ActivationHistocompatibility TestingT-LymphocytesBusulfanBone Marrow PurgingHistocompatibilityGraft RejectionHematopoietic Stem CellsImmunosuppressive AgentsTransplantation, IsogeneicCyclophosphamideTime FactorsMice, Inbred C57BLBone Marrow DiseasesRecurrenceHeart TransplantationHematopoiesisTreatment OutcomeImmunosuppressionRadiation ChimeraCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyLeukemia, Myeloid, AcuteLymphocyte DepletionLiving DonorsHematologic NeoplasmsBone Marrow ExaminationLung TransplantationGraft vs Host ReactionLeukocyte CountPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionHLA AntigensLymphocyte TransfusionHepatic Veno-Occlusive DiseaseAcute DiseaseBone RemodelingCyclosporineRetrospective StudiesLeukemia, MyeloidStem Cell TransplantationCells, CulturedFlow CytometryBone Marrow NeoplasmsLymphoma, Non-HodgkinLeukocyte TransfusionB-LymphocytesSpleenChimeraSurvival AnalysisLymphocyte SubsetsSevere Combined ImmunodeficiencyLymphocyte CountColony-Forming Units AssayCytomegalovirus InfectionsMyelodysplastic SyndromesMice, Inbred BALB CTransplantationFollow-Up StudiesHematologic DiseasesActuarial AnalysisCell DifferentiationBlood DonorsAntibodies, MonoclonalTransplantsSurvival RateBone DensityImmunophenotypingNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectAntilymphocyte SerumLymphomaOrgan TransplantationCarmustineCell SeparationAntigens, CDGraft vs Leukemia EffectThymus GlandPancytopeniaCytarabine